Here is the latest stock price and chart of Dishman Pharma. For more details, see the Dishman Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
REVEALED: How I Pick My 'Vertical Trades'...
Live BSE Quotes | May 29, 2017 (Close) | ||
---|---|---|---|
Price (Rs)301.05 | Open (Rs) 293.00 | High (Rs) 304.30 | Low (Rs) 278.10 |
% Change2.87 | Volume 460,499 | Value (Rs) 135,767,416 | 52-Week H/L 346.25 / 127.60 |
Live NSE Quotes | Mar 9, 2021 1:19:58 PM | ||
---|---|---|---|
Price (Rs)148.70 | Open (Rs) 150.95 | High (Rs) 151.00 | Low (Rs) 148.00 |
% Change-1.33 | Volume 9,083 | Value (Rs) 1,354,184 | 52-Week H/L 347.00 / 127.95 |
Change | |||||
---|---|---|---|---|---|
1 Day 2.87% | 1 Month -2.45% | 3 Months 30.49% | 1 Year 96.38% | 5 Years (CAGR)* 62.16% | 10 Years (CAGR)* 9.41% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 12.00 | P/E Ratio (x) 25.09 | Market Cap (Rs m) 48,587.66 | P/BV (x) 3.35 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
![]() |
||
S&P BSE SENSEX ![]() |
||||||
PERIOD |
DISHMAN PHARMA share price is down 1.3% to Rs 148.7 on the NSE. The total volume of shares traded is 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index is trading down by 0.8%. And the benchmark NIFTY 50 is at 14,945.1 (down 0.1%).
Over the last 30 days, the DISHMAN PHARMA share price is down 52.0%.
What else is happening in the markets today? Dig in...
Share markets in India are presently trading on a strong note. The BSE Sensex is trading up by 299 points, up 0.6% at 50,739 levels.
Sorry! There are no related views on news for this company/sector.
Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll show you how to get started on the path to daily trading profits.
This could be the biggest wealth creator of the decade.
In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.
More